Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This is a 12-month single center, randomized, open-label, single center study designed to
compare the safety and efficacy of everolimus and very low dose tacrolimus versus
enteric-coated sodium mycophenolate and low tacrolimus exposure in de novo kidney transplant
recipients.
The purpose of this study is to compare safety and efficacy of two immunosuppressive regimens
based on low tacrolimus exposure combined to everolimus or to enteric-coated mycophenolate
sodium (EC-MPS) in de novo kidney transplant recipients.